Follow the people · Insider
Francis Lo
Francis Lo files insider transactions with the SEC as a chief people officer of Adaptive Biotechnologies (ADPT). We hold 10 disclosed purchases and sales filed since 7 January 2020, 3 of them in the last 90 days.
- Files forADPT
- Disclosed buys and sells10 in all, 3 in the last 90 days
- Last disclosure17 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 July 2019 — 15 July 2026Chief People Officer · Adaptive Biotechnologies (ADPT)160 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 59,374 shares of Adaptive BiotechnologiesSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 23,677 shares of Adaptive BiotechnologiesSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 22,711 shares of Adaptive BiotechnologiesSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 105,762 shares of Adaptive BiotechnologiesSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 59,374 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 23,677 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 22,711 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 July 2026Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 3,500 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 12,637 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- ▼ sold on the open market 44,838 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- exercised options over 3,500 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 3,300 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 12,206 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 4,688 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 14,064 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 12,626 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 2 July 2026 · filed 6 July 2026
- exercised options over 12,600 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 2 July 2026 · filed 6 July 2026
- exercised options over 12,637 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 2 July 2026 · filed 6 July 2026
- exercised options over 3,300 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 12,206 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 4,688 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 14,064 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 8,743 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 42,261 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 12,626 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- exercised options over 12,600 shares of Adaptive BiotechnologiesSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- exercised options over 5,792 shares of Adaptive BiotechnologiesSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- exercised options over 2,009 shares of Adaptive BiotechnologiesSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- exercised options over 2,344 shares of Adaptive BiotechnologiesSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- exercised options over 9,376 shares of Adaptive BiotechnologiesSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- ▼ sold on the open market 39,741 shares of Adaptive BiotechnologiesSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- exercised options over 5,792 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 June 2026Stock Option (right to buy) · traded 4 June 2026 · filed 8 June 2026
- exercised options over 2,009 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 June 2026Stock Option (right to buy) · traded 4 June 2026 · filed 8 June 2026
- exercised options over 2,344 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 June 2026Stock Option (right to buy) · traded 4 June 2026 · filed 8 June 2026
- exercised options over 9,376 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 June 2026Stock Option (right to buy) · traded 4 June 2026 · filed 8 June 2026
- exercised options over 2,344 shares of Adaptive BiotechnologiesSEC Form 410 April 2026Common Stock · traded 8 April 2026 · filed 10 April 2026
- ▼ sold on the open market 22,564 shares of Adaptive BiotechnologiesSEC Form 410 April 2026Common Stock · traded 8 April 2026 · filed 10 April 2026
- exercised options over 2,344 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 410 April 2026Stock Option (right to buy) · traded 8 April 2026 · filed 10 April 2026
- ▼ sold on the open market 30,593 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 30,593 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 38,074 shares of Adaptive BiotechnologiesSEC Form 49 March 2026Common Stock · traded 5 March 2026 · filed 9 March 2026
- ▼ sold on the open market 38,074 shares of Adaptive BiotechnologiesSEC Form 49 March 2026Common Stock · traded 5 March 2026 · filed 9 March 2026
- was granted 44,063 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 44,063 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 36,650 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 7,723 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 21,002 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 36,650 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 7,723 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 21,002 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 14,215 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 14,215 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- ▼ sold on the open market 79,590 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 36,650 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 7,723 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 21,002 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 36,650 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 7,723 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 21,002 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 14,215 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- ▼ sold on the open market 79,590 shares of Adaptive BiotechnologiesSEC Form 414 January 2026Common Stock · traded 12 January 2026 · filed 14 January 2026
- exercised options over 14,215 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 414 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 2,194 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- exercised options over 2,194 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- ▼ sold on the open market 4,394 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- exercised options over 2,194 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 47 January 2026Stock Option (right to buy) · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 2,194 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- ▼ sold on the open market 4,394 shares of Adaptive BiotechnologiesSEC Form 47 January 2026Common Stock · traded 22 December 2025 · filed 7 January 2026
- exercised options over 3,125 shares of Adaptive BiotechnologiesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,125 shares of Adaptive BiotechnologiesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 3,125 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- exercised options over 3,125 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- exercised options over 3,125 shares of Adaptive BiotechnologiesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,125 shares of Adaptive BiotechnologiesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 429 December 2025Stock Option (right to buy) · traded 22 December 2025 · filed 29 December 2025
- exercised options over 2,194 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 429 December 2025Stock Option (right to buy) · traded 22 December 2025 · filed 29 December 2025
- exercised options over 1,100 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 429 December 2025Stock Option (right to buy) · traded 22 December 2025 · filed 29 December 2025
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- exercised options over 2,194 shares of Adaptive BiotechnologiesSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- exercised options over 1,100 shares of Adaptive BiotechnologiesSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- ▼ sold on the open market 4,394 shares of Adaptive BiotechnologiesSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- exercised options over 37,750 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 December 2025Stock Option (right to buy) · traded 15 December 2025 · filed 17 December 2025
- exercised options over 19,423 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 December 2025Stock Option (right to buy) · traded 15 December 2025 · filed 17 December 2025
- exercised options over 39,849 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 December 2025Stock Option (right to buy) · traded 15 December 2025 · filed 17 December 2025
- exercised options over 37,750 shares of Adaptive BiotechnologiesSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- exercised options over 19,423 shares of Adaptive BiotechnologiesSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- exercised options over 39,849 shares of Adaptive BiotechnologiesSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 113,890 shares of Adaptive BiotechnologiesSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- was granted 150,024 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2025Stock Option (right to buy) · traded 4 March 2025 · filed 6 March 2025
- was granted 99,976 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- ▼ sold on the open market 7,085 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- ▼ sold on the open market 13,790 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- was granted 150,024 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2024Stock Option (right to buy) · traded 4 March 2024 · filed 6 March 2024
- was granted 99,976 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- ▼ sold on the open market 12,887 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 5 March 2024 · filed 6 March 2024
- ▼ sold on the open market 1,813 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 5 March 2024 · filed 6 March 2024
- was granted 128,599 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2023Stock Option (right to buy) · traded 6 March 2023 · filed 8 March 2023
- was granted 85,697 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- ▼ sold on the open market 6,816 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- ▼ sold on the open market 3,582 shares of Adaptive BiotechnologiesSEC Form 410 March 2022Common Stock · traded 8 March 2022 · filed 10 March 2022
- was granted 185,338 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2022Stock Option (Right to Buy) · traded 4 March 2022 · filed 8 March 2022
- was granted 74,135 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 4 March 2022 · filed 8 March 2022
- ▼ sold on the open market 1,569 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 7 March 2022 · filed 8 March 2022
- exercised options over 2,000 shares of Adaptive BiotechnologiesSEC Form 417 May 2021Common Stock · traded 14 May 2021 · filed 17 May 2021
- ▼ sold on the open market 2,000 shares of Adaptive BiotechnologiesSEC Form 417 May 2021Common Stock · traded 14 May 2021 · filed 17 May 2021
- exercised options over 2,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 May 2021Stock Option (Right To Buy) · traded 14 May 2021 · filed 17 May 2021
- exercised options over 2,000 shares of Adaptive BiotechnologiesSEC Form 416 April 2021Common Stock · traded 15 April 2021 · filed 16 April 2021
- ▼ sold on the open market 2,000 shares of Adaptive BiotechnologiesSEC Form 416 April 2021Common Stock · traded 15 April 2021 · filed 16 April 2021
- exercised options over 2,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 416 April 2021Stock Option (Right To Buy) · traded 15 April 2021 · filed 16 April 2021
- exercised options over 2,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 March 2021Stock Option (Right To Buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 2,000 shares of Adaptive BiotechnologiesSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- ▼ sold on the open market 878 shares of Adaptive BiotechnologiesSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.